Immunotherapy, a rapidly evolving field in oncology, has revolutionized the treatment landscape for numerous cancers. It harnesses the power of the body's immune system to combat malignancies, offering a novel approach to cancer therapy. This article aims to provide a comprehensive guide to physicians about the essentials of immunotherapy.
Immunotherapy functions by boosting the immune system's natural defenses to fight cancer cells. It can be broadly categorized into several types: immune checkpoint inhibitors, cancer vaccines, monoclonal antibodies, and non-specific immunotherapies. Each type works differently but all aim to stimulate or restore the immune system's ability to detect and eliminate cancer cells.
Immunotherapy has shown efficacy in treating a variety of cancers, including melanoma, lung, kidney, bladder, and head and neck cancers. Its use is determined by factors such as the type and stage of cancer, overall health of the patient, and previous treatments. It is often used in combination with other treatments like chemotherapy, radiation, or surgery to increase effectiveness.
While immunotherapy has transformed cancer treatment, it also presents unique adverse effects, often termed immune-related adverse events (irAEs). These include inflammation of organs such as the lungs, intestines, liver, and endocrine glands. Effective management of irAEs is crucial and involves a balance between treating the side effects and maintaining the anti-cancer efficacy of the therapy.
Immunotherapy is a dynamic field with ongoing research exploring new targets, combination strategies, and predictive biomarkers. The future holds promise for more effective and personalized immunotherapies, potentially transforming the prognosis for many cancer patients.
As immunotherapy continues to evolve, staying abreast of the latest advancements is crucial for physicians. Understanding the essentials of immunotherapy, its application, adverse effects, and future directions, enables physicians to provide optimal care for their patients, enhancing survival and quality of life.
1.
Imetelstat for MDS-relateret anemia er godkendt af Food and Drug Administrations panel.
2.
Navigating breast cancer diagnosis, treatment, and survivorship in Ethiopia
3.
No Gestational Diabetes-Cancer Link; Cholesterol and Cancer; Oncologist Saves Umpire
4.
Specialized imaging improves overall prostate cancer survival by identifying benefits of salvage radiotherapy
5.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
1.
Ferroptosis as a Therapeutic Target in Cancer
2.
Subchorionic Hematoma: Causes, Symptoms, and Treatment
3.
Adaptive Cell Therapies for Solid Tumors
4.
Engineered Niches for Blood-Cell Regeneration: Current Concepts and Clinical Implications
5.
Unlocking the Potential of Hemin: A Novel Approach to Health and Wellbeing
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
2.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
5.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation